Myelodysplasia and acute myelogenous leukemia after myeloablative therapy with autologous stem-cell transplantation.
Rohatiner
A
A
D000328:Adult; D005500:Follow-Up Studies; D018380:Hematopoietic Stem Cell Transplantation / Q000009:adverse effects*; D006689:Hodgkin Disease / Q000628:therapy; D006801:Humans; D015994:Incidence; D015470:Leukemia, Myeloid, Acute / Q000453:epidemiology / Q000209:etiology*; D008228:Lymphoma, Non-Hodgkin / Q000628:therapy; D009190:Myelodysplastic Syndromes / Q000453:epidemiology / Q000209:etiology*; D012307:Risk Factors